Digital health provider Lifespot Health (ASX: LSH) is edging into Israel’s medical cannabis market after entering discussions to have its Seng Vital vaporiser, which comprises the certified BodyTel software platform, used in upcoming clinical trials that Israel-based companies are carrying out with a view to commercialising the product in the region.
An Israeli Medical Marijuana company funding clinical trials of Seng Vital's vaporizer.
That is enough validation for me that this technology has potential. Someone is willing to stump up $Mils for clinical trials, research and bringing the product to market.
Digital health provider Lifespot Health (ASX: LSH) is edging...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.262M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 45000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 4400 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable